Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18163521rdf:typepubmed:Citationlld:pubmed
pubmed-article:18163521lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0443315lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0001563lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0025677lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0282462lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:18163521lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:18163521pubmed:issue1lld:pubmed
pubmed-article:18163521pubmed:dateCreated2008-1-21lld:pubmed
pubmed-article:18163521pubmed:abstractTextTo compare the efficacy and safety of subcutaneous (SC) versus oral administration of methotrexate (MTX) in patients with active rheumatoid arthritis (RA).lld:pubmed
pubmed-article:18163521pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18163521pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18163521pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18163521pubmed:languageenglld:pubmed
pubmed-article:18163521pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18163521pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18163521pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18163521pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18163521pubmed:statusMEDLINElld:pubmed
pubmed-article:18163521pubmed:monthJanlld:pubmed
pubmed-article:18163521pubmed:issn0004-3591lld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:BraunJJlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:HankePPlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:KästnerPPlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:BrandtAAlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:HeitzWWlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:von HinüberUUlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:WährischJJlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:PichlmeierUUlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:DemaryWWlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:FlaxenbergPPlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:RockwitzKKlld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:Guimbal-Schmo...lld:pubmed
pubmed-article:18163521pubmed:authorpubmed-author:MC-MTX.6/RH...lld:pubmed
pubmed-article:18163521pubmed:issnTypePrintlld:pubmed
pubmed-article:18163521pubmed:volume58lld:pubmed
pubmed-article:18163521pubmed:ownerNLMlld:pubmed
pubmed-article:18163521pubmed:authorsCompleteYlld:pubmed
pubmed-article:18163521pubmed:pagination73-81lld:pubmed
pubmed-article:18163521pubmed:dateRevised2008-11-13lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:meshHeadingpubmed-meshheading:18163521...lld:pubmed
pubmed-article:18163521pubmed:year2008lld:pubmed
pubmed-article:18163521pubmed:articleTitleComparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.lld:pubmed
pubmed-article:18163521pubmed:affiliationRheumazentrum Ruhrgebiet, Herne, Germany. J.Braun@rheumazentrum-ruhrgebiet.delld:pubmed
pubmed-article:18163521pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18163521pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18163521pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18163521pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18163521pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:18163521pubmed:publicationTypeClinical Trial, Phase IVlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18163521lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18163521lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18163521lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18163521lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18163521lld:pubmed